Generating Insights Through the Exploration of Real World Data in IBD

Inflammatory Bowel Disease (IBD) is a chronic gastrointestinal disorder characterized by inflammation of the digestive tract, leading to severe symptoms and a significant reduction in patient quality of life.

‍

Despite advancements in treatment, many patients do not respond adequately to existing therapies.

‍

This case study demonstrates how Panomics, an advanced bioinformatics platform, integrates real-world data (RWD) with public datasets to uncover novel biomarkers and therapeutic targets in IBD.

‍

By enabling no-code data exploration and analysis, Panomics empowers researchers to overcome the complexities of large, heterogeneous datasets, facilitating precision medicine approaches in IBD care.

‍

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Trusted by the world's biopharma leaders